Elana Thieme wins Abstract Achievement Award at the 62nd ASH Annual Meeting in Atlanta for her presentation "Pharmacologic inhibition of B cell-receptor-associated kinases with CG-806 induces apoptosis and metabolic reprogramming in aggressive NHL models"
February 2021
NIH R01 “Overcoming ibrutinib resistance in Mantle cell lymphoma”
April 2021
Tingting Liu wins a Scholar in Training Award at AACR Annual Meeting for her presentation “Pharmacologic targeting Mcl-1 with AZD5991 induces apoptosis, suppresses mitochondrial respiration and overcomes ibrutinib resistance in NHL cells
April 2021
Lab moves to City of Hope National Medical Center
December 2019
Max Gordon wins Abstract Achievement Award at the 61stASH Annual Meeting in Atlanta for his presentation "The CLL Comorbidity Index (CLL-CI): a Novel Comorbidity Score"
September 2019
Scott Best wins a travel award to deliver an oral presentation at IWCLL2019 in Edinburgh, Scotland “Pevonedistat, a NAE inhibitor, is a favorable modulator of T cell function in ex vivo studies of CLL”
December 2018
Max Gordon wins Abstract Achievement Award at the 60th ASH Annual Meeting in Atlanta for his presentation "Impact of individual comorbidities on treatment outcomes in chronic lymphocytic leukemia"
September 2018
Scott Best wins Best Abstract Award for his oral presentation "TAK-243, a small molecule inhibitor of ubiquitin-activating enzyme (UAE), induces ER stress and apoptosis in CLL cells" at the NewYoung Investigator Meeting at the International Workshop on CLL in Cologne, Germany
July 2018
Alexey Danilov becomes a Leukemia and Lymphoma Society Scholar in Clinical Research
December 2017
Max Gordon wins Abstract Achievement Award at the 59th ASH Annual Meeting in Atlanta for his oral presentation "Medical comorbidities assessed by CIRS negatively impact survival in the era of targeted therapies in CLL: a multicenter retrospective analysis"
Scott Best wins Abstract Achievement Award at the 59th ASH Annual Meeting in Atlanta for his presentation "TAK-243, a small molecule inhibitor of ubiquitin-activating enzyme, induces ER stress and apoptosis in diffuse large B-cell lymphoma cells"
June 2017
Danilov lab awarded a Leukemia and Lymphoma Society Translational Research Program award
December 2016
Taylor Hashiguchi gives an oral presentation at the 58th ASH Annual Meeting in San Diego "Selective targeting cyclin-dependent kinase-9 (CDK9) downmodulates c-MYC and induces apoptosis in diffuse large B-cell lymphoma (DLBCL) cells"
Cody Paiva wins Abstract Achievement Award at the 58th ASH Annual Meeting in San Diego for his oral presentation "SYK inhibition disrupts the cross-talk between B-cell activation factor (BAFF) and B-cell receptor (BCR) and thereby antagonizes Mcl-1 in CLL B-cells"